Skip to Content Skip to Content

School of Veterinary Medicine

Visit the School's Site
Commonalities in Late Stages of Different Inherited Blinding Diseases Suggest Targets for Therapy

Commonalities in Late Stages of Different Inherited Blinding Diseases Suggest Targets for Therapy

Gene therapy holds promise for treating a variety of diseases, including some inherited blinding conditions. But for a gene therapy to be effective, one must know the precise gene responsible for a given individual’s disorder and develop a tailored treatment.

Katherine Unger Baillie

FDA Approves Gene Therapy for Inherited Blindness Developed by Penn and CHOP

FDA Approves Gene Therapy for Inherited Blindness Developed by Penn and CHOP

In a historic move, the U.S. Food and Drug Administration (FDA) today approved a gene therapy initially developed by researchers at the University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP) for the treatment of a rare, inherited form of retinal blindness.

Katie Delach

Four Penn Professors Among 2017 Class of AAAS Fellows

Four Penn Professors Among 2017 Class of AAAS Fellows

Four members of the University of Pennsylvania faculty have been named Fellows of the American Association for the Advancement of Science. Election as an AAAS Fellow is an honor bestowed upon members of AAAS, the world’s largest general scientific society, by their peers.

Katherine Unger Baillie , Greg Richter , Ali Sundermier

Taking Blood Using ‘Push-Pull’ Method Gets Accurate Results With Fewer Pokes, Penn Study Shows

Taking Blood Using ‘Push-Pull’ Method Gets Accurate Results With Fewer Pokes, Penn Study Shows

A new study by University of Pennsylvania veterinary researchers has found that blood samples collected from an intravenous catheter using a special “mixing” technique are as accurate as those collected via venipuncture, in which a needle is used to access the vein directly.

Katherine Unger Baillie

Targeting enzyme in ‘normal’ cells may impede pancreatic cancer’s spread, Penn Vet team shows

Targeting enzyme in ‘normal’ cells may impede pancreatic cancer’s spread, Penn Vet team shows

Cancer of the pancreas is a deadly disease, with a median survival time of less than six months. Only one in 20 people with pancreatic cancer survives five years past the diagnosis. The reason is the cancer’s insidiousness; tumor cells hide deep inside the body, betraying no symptoms until late in the disease, when the cancer has almost invariably spread to other organs.

Katherine Unger Baillie

Penn Study Shows How Female Immune Cells Keep Their Second X Chromosome Shut Off

Penn Study Shows How Female Immune Cells Keep Their Second X Chromosome Shut Off

Autoimmune diseases tend to strike women more than men and having multiple X chromosomes could be the main reason why. While a process called X chromosome inactivation serves to balance out gene dosage between males and females, some genes on the “inactive X” chromosome in immune cells can sometimes escape this process, giving women an extra dose of immunity-related gene expression.

Katherine Unger Baillie

Penn Team Shows How Seemingly Acute Viral Infections Can Persist

Penn Team Shows How Seemingly Acute Viral Infections Can Persist

Infections caused by viruses, such as respiratory syncytial virus, or RSV, measles, parainfluenza and Ebola, are typically considered acute. These viruses cause disease quickly and live within a host for a limited time. But in some cases the effects of the infection, and presence of the virus itself, can persist.

Katherine Unger Baillie

Confronted With Bacteria, Infected Cells Die So Others Can Live, Penn Study Finds

Confronted With Bacteria, Infected Cells Die So Others Can Live, Penn Study Finds

The immune system is constantly performing surveillance to detect foreign organisms that might do harm. But pathogens, for their part, have evolved a number of strategies to evade this detection, such as secreting proteins that hinder a host’s ability to mount an immune response.

Katherine Unger Baillie